MARKHAM, Ontario, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a "Common Share") for the month of February 2024, representing $0.936 per Common Share on an annualized basis.
The dividend will be payable on March 15, 2024 to shareholders of record as at February 29, 2024.
The Company's dividends are designated as eligible dividends for Canadian tax purposes in accordance with subsection 89(14) of the Income Tax Act (Canada), and any applicable corresponding provincial and territorial legislation.
About Sienna Senior Living
Sienna Senior Living Inc. (TSX:SIA) offers a full range of senior living options, including independent living, assisted living and memory care under its Aspira retirement brand, long-term care, and specialized programs and services. Sienna's approximately 12,000 employees are passionate about cultivating happiness in daily life. For more information, please visit www.siennaliving.ca.
For further information, please contact: David Hung Chief Financial Officer & Executive Vice President (905) 489-0258 [email protected]
Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has successfully completed 11 installs of its eProtein Discoverytm system, including at leading...
AMRA Medical - a health informatics and precision medicine company that is pioneering body composition research through gold-standard MRI-based analysis platforms - collaborated on a study driven by University of Texas Southwestern and University...
Direct Care Workforce Strategies Center to host learning collaboratives to share best practices
Key Takeaways
-- 14 states have been selected to participate in the Direct Care Workforce Strategies Center's new State Peer-Learning Collaboratives.
--...
Regulatory News:
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery announces that all resolutions proposed at its Annual General Meeting held today were...
Every year, over 500,000 kids in the US are rushed to the emergency room because of asthma. While rescue inhalers can prevent attacks from becoming life-threatening, many kids aren't using them like they should. Because kids with asthma often feel...
A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seasons in the United States. The study suggests that cell-based quadrivalent influenza vaccine (QIVc) may have the...
